← Back to Search

N/A

Spectrum Research Cigarettes for Smoking/Cigarette Smoking (CENIC2-P3 Trial)

N/A
Waitlist Available
Led By Suzanne Colby, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline-lab session 5; 2-8 weeks; average 3-4 weeks
Awards & highlights

CENIC2-P3 Trial Summary

This trial is testing how different levels of nicotine in cigarettes and e-liquids affects how adolescents smoke them.

Eligible Conditions
  • Smoking/Cigarette Smoking
  • Electronic Cigarettes

CENIC2-P3 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline-lab session 5; 2-8 weeks; average 3-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline-lab session 5; 2-8 weeks; average 3-4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Cigarette Puffs Taken (0 to 20)
Number of Cigarette Puffs Taken (0 to 20) When the Available Vaping Device Has 18mg/ml of Nicotine and Was Available in Non-tobacco Flavors
Number of Cigarette Puffs Taken (0 to 20) When the Available Vaping Device Has 18mg/ml of Nicotine and Was Available in Tobacco Flavor
+2 more
Secondary outcome measures
Carbon Monoxide Change From pre-to the Post-choice Task When no Vaping Device Was Available
Carbon Monoxide Change From pre-to the Post-choice Task When the Available Vaping Device Contained 18mg/ml Nicotine and Was Available in Non-tobacco Flavors
Carbon Monoxide Change From pre-to the Post-choice Task When the Available Vaping Device Contained 18mg/ml Nicotine and Was Available in Tobacco Flavor
+6 more
Other outcome measures
Blood Pressure
Carbon Monoxide (CO)
Cigarette Evaluation Scale (CES)
+13 more

CENIC2-P3 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Very Low Nicotine Content CigarettesExperimental Treatment1 Intervention
Spectrum Research Cigarettes: 0.4 mg nicotine/g tobacco, 9 mg of tar
Group II: Normal Nicotine Content CigarettesActive Control1 Intervention
Spectrum Research Cigarettes: 15.8 mg nicotine/g tobacco, 9 mg of tar
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spectrum Research Cigarettes
2018
N/A
~80

Find a Location

Who is running the clinical trial?

Wake Forest UniversityOTHER
188 Previous Clinical Trials
164,457 Total Patients Enrolled
Brown UniversityLead Sponsor
456 Previous Clinical Trials
563,001 Total Patients Enrolled
Food and Drug Administration (FDA)FED
171 Previous Clinical Trials
1,331,526 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluating New Nicotine Standards for Cigarettes - Project 3
Suzanne M. Colby 2018. "Evaluating New Nicotine Standards for Cigarettes - Project 3". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03194256.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top